Source Natural Foods
115.00
+1.80(+1.59%)
Market Cap₹74.06 Cr
PE Ratio21.44
IndustryHealthcare
Company Performance:
1D+1.59%
1M+6.73%
6M+2.54%
1Y-17.86%
5Y-19.83%
View Company Insightsright
More news about Source Natural Foods
30May 26
Source Natural Foods reports FY26 net profit of ₹339.94 crore
Source Natural Foods and Herbal Supplements Limited reported a 17% increase in net profit to ₹339.94 crore for FY26, with revenue rising 56% to ₹7,043.25 crore. For the quarter ended March 31, 2026, net profit surged 98% to ₹124.47 crore. The Board approved the audited results and re-appointed auditors for FY27.
 no imag found
28May 26
Source Natural Foods re-appoints auditors for FY27
Source Natural Foods and Herbal Supplements Limited has re-appointed M/s. Chiranjeevulu Jeelaga & Co. as Cost Auditor and M/s. Ganga Prakash & Co. as Internal Auditor for FY27. The Board approved these appointments on May 28, 2026, under Regulation 30 of SEBI LODR Regulations.
 no imag found
10Apr 26
Source Natural Foods Submits Q4FY26 Certificate Under SEBI Depositories Regulations
Source Natural Foods and Herbal Supplements Limited submitted its Q4FY26 certificate under SEBI Depositories Regulations to BSE Limited on April 9, 2026. The certificate, issued by registrar Venture Capital and Corporate Investments Private Limited, confirms compliance with dematerialization requirements for securities processed through NSDL and CDSL depositories within the mandatory 15-day period.
 no imag found
06Mar 26
Source Natural Foods Transfers Solar Project to Subsidiary and Incorporates New WOS for Green Energy Expansion
Source Natural Foods and Herbal Supplements Limited approved the transfer of its 2 MW solar project in Odisha to wholly owned subsidiary Source Natural Solar Private Limited and the incorporation of a new subsidiary in Karnataka during its March 6, 2026 board meeting. The company has successfully commissioned a 0.5 MW rooftop solar project in Bangalore and secured 140 projects under PM Surya Ghar Yojana in recent months. The strategic moves support the company's renewable energy expansion through dedicated SPVs for efficient project management and operations.
 no imag found
14Feb 26
Source Natural Foods Reports Q3FY26 Results and Approves Green Energy Investments
Source Natural Foods announced Q3FY26 financial results showing total revenue of ₹2164.41 lakhs and EBITDA of ₹152.90 lakhs. The Ayurveda segment contributed ₹1461.23 lakhs while the Energy segment generated ₹703.18 lakhs. The board approved strategic investments of up to ₹10 crore each for subsidiary loans and equity capital in green energy projects.
 no imag found
11Feb 26
Source Natural Foods Incorporates Wholly-Owned Solar Subsidiary for Power Generation
Source Natural Foods and Herbal Supplements Limited has incorporated Source Natural Solar Private Limited as a wholly-owned subsidiary on February 06, 2026. The subsidiary has an authorized capital of Rs. 10,00,000 and paid-up capital of Rs. 1,00,000, with the parent company holding 100% shareholding through cash investment. The new entity will focus on developing and operating grid-connected Solar PV power projects, marking the company's strategic expansion into renewable energy sector.
 no imag found
13Aug 25
Source Natural Foods Approves Q1 Results, Appoints New Managing Director
Source Natural Foods and Herbal Supplements Limited announced key corporate developments following its board meeting on August 13, 2025. The board approved unaudited Q1 financial results ending June 30, 2025. Mr. Arvind Varchaswi was appointed as the new Managing Director for a five-year term, subject to shareholder approval. The board recommended the reappointment of Mr. Narayanan Narasimhan as Non-Executive Director and Chairperson. New appointments include M/s. KKR & Associates as Secretarial Auditor and M/s. Chiranjeevulu Jeelaga & Co. as Cost Auditors. The board also reviewed internal audit reports, related party transactions, and compliance statements.
 no imag found
Source Natural Foods
115.00
+1.80
(+1.59%)
1 Year Returns:-17.86%
Industry Peers
Sun Pharmaceutical
1,846.40
(-1.20%)
Divis Laboratories
9,352.00
(-0.62%)
Torrent Pharmaceuticals
4,935.00
(-0.70%)
Zydus Life Science
1,162.30
(+0.11%)
Cipla
1,384.10
(-0.14%)
Laurus Labs
2,006.50
(-0.55%)
Mankind Pharma
2,480.00
(+1.73%)
Dr Reddys Laboratories
1,211.00
(+1.06%)
Aurobindo Pharma
1,700.00
(-0.78%)
Lupin
2,135.00
(+0.49%)